Search

Champions Oncology Inc

Cerrado

SectorSanidad

4.99 -0.8

Resumen

Variación precio

24h

Actual

Mínimo

4.91

Máximo

5.15

Métricas clave

By Trading Economics

Ingresos

-389K

-667K

Ventas

-2.7M

14M

P/B

Media del Sector

35.118

57.002

BPA

-0.05

Margen de beneficios

-4.821

Empleados

214

EBITDA

-278K

-174K

Dividendos

By Acuity

Próximas Ganancias

11 sept 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-13M

71M

Apertura anterior

5.79

Cierre anterior

4.99

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

171 / 340 Clasificación en Healthcare

Champions Oncology Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 ago 2026, 19:26 UTC

Champions Oncology Inc shares are higher during Thursday's session, rebounding from an earlier dip despite remaining below the 20-day moving average.

12 ago 2026, 19:51 UTC

Champions Oncology Inc's shares are lower today, diverging from recent gains, with no specific news identified to explain the decline.

11 ago 2026, 19:41 UTC

Champions Oncology Inc shares are lower today amid no specific news. The stock remains below its 20-day moving average and near the month's low.

10 ago 2026, 19:31 UTC

Champions Oncology Inc shares are lower, continuing a decline since Friday's close. The stock remains near its one-month range's lower end.

7 ago 2026, 19:42 UTC

Champions Oncology Inc shares are higher, driven by gains in the Life Sciences Tools & Services sub-sector. Earlier, they pulled back from a session high.

6 ago 2026, 19:32 UTC

Champions Oncology Inc shares are lower, continuing a downward trend amid broader market concerns over inflation and Federal Reserve policy. No specific news was identified.

5 ago 2026, 19:31 UTC

Champions Oncology Inc shares are lower during Wednesday's session, reflecting significant volatility amid broader market conditions and a notable drop in crude oil prices.

4 ago 2026, 19:51 UTC

Champions Oncology Inc shares are lower today, influenced by a decline in the Life Sciences Tools & Services sub-sector. The stock remains below its 20-day moving average.

3 ago 2026, 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

31 jul 2026, 19:46 UTC

Champions Oncology Inc shares are higher today, reflecting a positive move since Thursday's close, though still below the 20-day moving average.

30 jul 2026, 17:16 UTC

Champions Oncology is trading lower today, continuing a trend of declines over the past three sessions, despite positive broader market sentiment.

29 jul 2026, 19:02 UTC

Champions Oncology Inc is trading higher during Wednesday's session, breaking from its recent upward trend. Broader market dynamics are influenced by rising oil prices.

28 jul 2026, 19:32 UTC

Champions Oncology Inc. shares are trading lower amid broader market declines, particularly in technology sectors across Asia, with no specific company news identified.

27 jul 2026, 23:01 UTC

News

Champions Oncology shares declined in after-market trading following mixed fourth-quarter earnings, despite adjusted EPS of $0.01 and record annual revenue of $59.4 million.

24 jul 2026, 20:06 UTC

Champions Oncology Inc shares are advancing, despite earlier intraday volatility. Broader market sentiment reflects easing inflation concerns amid significant oil price drops.

22 jul 2026, 19:41 UTC

Champions Oncology shares are declining during Wednesday's session, with no specific news identified. Broader market concerns are driven by rising crude oil prices.

Comparación entre iguales

Cambio de precio

Champions Oncology Inc previsión

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

171 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat